CoDiagnostics (CODX)
(Real Time Quote from BATS)
$1.30 USD
-0.05 (-3.70%)
Updated Jul 15, 2024 02:52 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Price, Consensus and EPS Surprise
CODX 1.30 -0.05(-3.70%)
Will CODX be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for CODX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CODX
Elevance Health (ELV) Beats Q1 Earnings Estimates
Icon PLC (ICLR) Q4 Earnings Surpass Estimates
CODX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Co-Diagnostics, Inc. (CODX) Reports Q2 Loss, Lags Revenue Estimates
Sharecare, Inc. (SHCR) Reports Q2 Loss, Tops Revenue Estimates
Co-Diagnostics, Inc. (CODX) Reports Q1 Loss, Lags Revenue Estimates
Other News for CODX
Co-Diagnostics, Inc. Expands Vector Control Customer Base to 25 Customers across 15 U.S. States
IN BRIEF: Codex Acquisitions focused on reverse takeover; loss narrows
Co-Diagnostics, Inc. to Participate at FIME 2024 in Miami Beach, June 19-21
Analysts Have Conflicting Sentiments on These Healthcare Companies: Mirum Pharmaceuticals (MIRM) and Co-Diagnostics (CODX)
Co-Diagnostics, Inc. Submits First FDA 510(k) Application for Co-Dx PCR Pro Platform